CellAegis Announces Completion of Patient Enrollment in Danish Investigator Sponsored Clinical Trial Using autoRIC Device
TORONTO, Canada, May 17, 2018 – CellAegis Devices Inc. (“CellAegis” or the “Company”) a commercial-stage...
Search for Articles
May 17, 2018
May 8, 2018
CellAegis to complete enrollment in U.S. autoRIC trial by end of 2018
In addition to several large ongoing investigator-sponsored studies in Europe and Canada using its autoRIC...
Apr 23, 2018
VGS Initiates U.S. Pivotal Trial to Evaluate the Use of Its VEST Technology for Bypass Surgery
TEL AVIV, Israel, April 23, 2018 /PRNewswire/ -- Vascular Graft Solutions Ltd (VGS) announces on...
Apr 16, 2018
Herantis Pharma announces positive interim data from Lymfactin study in secondary lymphedema
Herantis Pharma PlcCompany release 16 Apr 2018 at 9:00 am Herantis Pharma Plc (“Herantis”) announced...
Apr 10, 2018
CellAegis Announces First Patients Enrolled in U.S. Shield Pivotal Clinical Trial
TORONTO, Canada, April 10, 2018 (GLOBE NEWSWIRE) – CellAegis Devices Inc. (“CellAegis” or the “Company”),...
Mar 12, 2018
Acesion Pharma Commences Phase 1 Study in Atrial Fibrillation
COPENHAGEN, Denmark— 12 March 2018: Acesion Pharma (“Acesion” or the Company), a Danish biotech company...